Biotechnology

Filter

Current filters:

None

Popular Filters

226 to 250 of 2250 results

Celgene gains rights to Nogra product in potential $1 billion-plus deal

Celgene gains rights to Nogra product in potential $1 billion-plus deal

24-04-2014

US biotech firm Celgene has entered a global license agreement with privately-held Irish company Nogra…

Anti-Arthritics/RheumaticsBiotechnologyCelgeneGED-0301LicensingNogra Pharma

Celgene beats expectations, despite profit downturn

24-04-2014

US biotech firm Celgene saw its shares fall 3.3% to $140.05 in mid-morning trading after it posted first-quarter…

BiotechnologyCelgeneFinancial

WuXi PharmaTech announces Management Appointments

WuXi PharmaTech announces Management Appointments

24-04-2014

China’s WuXi PharmaTech (NYSE: WX) has announced that Dr Steve Yang has joined the company as Executive…

BiotechnologyBoardroomChinaPharmaceuticalWuXi PharmaTech

Hyperion Therapeutics to broaden orphan disease pipeline with buy of Israeli firm

24-04-2014

US biotech firm Hyperion Therapeutics has entered into a definitive agreement to acquire Andromeda Biotech,…

Andromeda BiotechBiotechnologyDiabetesDiaPep277Hyperion TherapeuticsMergers & Acquisitions

CT Catapult to work with Athersys to advance European development of MultiStem therapy

24-04-2014

The Cell Therapy Catapult, which is focused on the development of the UK cell therapy industry to increase…

AthersysBiotechnologyCell Therapy CatapultEuropeMarkets & MarketingResearch

Impax Laboratories appoints Frederick Wilkinson as President and CEO

Impax Laboratories appoints Frederick Wilkinson as President and CEO

24-04-2014

US generic drugmaker Impax Laboratories (NASDAQ: IPXL) has announced the appointment of Frederick Wilkinson…

BiotechnologyBoardroomImpax LaboratoriesPharmaceuticalUSA

Lupin inks strategic biosimilars joint venture agreement with Yoshindo

23-04-2014

Indian drugmaker Lupin has entered into a strategic joint venture agreement with Japanese pharma company,…

BiosimilarsBiotechnologyEnbrelInflammatory diseasesJapanLicensingLupinTakeda PharmaceuticalYoshindo

Biogen Idec 1st-qtr 2014 revenue leaps 51%, driven by Tecfidera and MS franchise

23-04-2014

US biotech firm Biogen Idec first-quarter 2014 results today, including revenue of $2.1 billion, a 51%…

Biogen IdecBiotechnologyFinancialNeurologicalResearchTecfidera

Amgen's 1st-qtr 2014 disappoints, as net income falls 25%

23-04-2014

Amgen, the world’s largest independent biotech firm by revenues, yesterday announced financial results…

AmgenBiotechnologyFinancialResearch

Bristol-Myers Squibb and Samsung BioLogics expand manufacturing deal

23-04-2014

US drug major Bristol-Myers Squibb and South Korea’s Samsung BioLogics revealed that they will increase…

Asia-PacificBiotechnologyBristol-Myers SquibbProductionSamsung BioLogics

ReNeuron Group announce recruitment for new Chief Executive

ReNeuron Group announce recruitment for new Chief Executive

23-04-2014

UK-based stem cell therapy company ReNeuron Group has announced the recruitment for a new Chief Executive…

BiotechnologyBoardroomReNeuronUK

Gilead 1st-qtr 2014 sales nearly double, fuelled by Sovaldi, as net income rockets

23-04-2014

US antivirals major Gilead Sciences posted first-quarter 2014 results after markets closed yesterday,…

Anti-viralsBiotechnologyFinancialGilead SciencesSovaldi

Epizyme earns $4 million milestone under GSK collaboration

22-04-2014

US clinical-stage biopharma firm Epizyme announced the achievement of the lead candidate milestone for…

BiotechnologyEpizymeFinancialGlaxoSmithKlineLicensingOncology

AusBiotech to submit to Senate’s Australian innovation system inquiry

22-04-2014

Trade group AusBiotech is preparing a submission, following the Senate's referral of an inquiry into…

Asia-PacificAustraliaBiotechnologyFinancialResearch

Sentinel Oncology in deal with Oncothyreon worth a potential $174 million

22-04-2014

UK-based small molecule drug discovered Sentinel Oncology has signed a collaboration agreement with the…

BiotechnologyLicensingOncologyOncothyreonResearchSentinel Oncology

Sanofi divests Cell Therapy and Regenerative Medicine business to Aastrom

22-04-2014

US cardiovascular drug developer Aastrom Biosciences has entered into a definitive agreement to acquire…

Aastrom BiosciencesBiotechnologyMergers & AcquisitionsSanofi

US FDA clears pathway for Sarepta’s eteplirsen filing by year end

22-04-2014

US RNA-based drug developer Sarepta Therapeutics it plans to submit a New Drug Application to the US…

BiotechnologyeteplirsenNorth AmericaRare diseasesRegulationSarepta TherapeuticsUSA

Biogen Idec exercises option for Amunix’ XTENylated Factor VIII

21-04-2014

US privately-held biotech firm Amunix Operating says that Biogen Idec has exercised its option to enter…

AmunixBiogen IdecBiotechnologyHematologyLicensing

NHS England agrees funding for Gilead’s hepatitis C drug Sovaldi

18-04-2014

NHS England has approved an £18.7 million ($31.3 million) investment in a new drug for the treatment…

Anti-viralsBiotechnologyFinancialGilead SciencesHealthcareNorthern EuropeSovaldiUK

First Asian approval for ophthalmic drug Jetrea, in Malaysia

18-04-2014

Belgian biotech firm ThromboGenics NV revealed today that Jetrea (ocriplasmin) has been approved in Malaysia…

AlconAsia-PacificBiotechnologyJetreaMalaysiaNovartisOphthalmicsRegulationThromboGenics

Actelion posts strong first-quarter 2014 results

Actelion posts strong first-quarter 2014 results

17-04-2014

Switzerland’s Actelion today announced financial results for the first three months of 2014, showing…

ActelionBiotechnologyFinancial

Epirus to acquire Zalicus, creating a publicly-traded biosimilars enterprise

16-04-2014

Boston-based privately-held Epirus Biopharmaceuticals, focused on the global development and commercialization…

BiosimilarsBiotechnologyEPIRUS BiopharmaceuticalsMergers & AcquisitionsZalicus

226 to 250 of 2250 results

Back to top